Lsb Industries [LXU] vs Asp Isotopes [ASPI] Detailed Stock Comparison
Lsb Industries
NYSE
Loading...
Asp Isotopes
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Lsb Industries wins in 11 metrics, Asp Isotopes wins in 7 metrics, with 0 ties. Lsb Industries appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Lsb Industries | Asp Isotopes | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 210.50 | -15.52 | Asp Isotopes |
| Price-to-Book Ratio | 1.04 | 16.47 | Lsb Industries |
| Debt-to-Equity Ratio | 98.92 | 84.08 | Asp Isotopes |
| PEG Ratio | 12.79 | -64.80 | Asp Isotopes |
| EV/EBITDA | 12.07 | -26.48 | Asp Isotopes |
| Profit Margin (TTM) | -6.16% | 38.60% | Asp Isotopes |
| Operating Margin (TTM) | 8.59% | -721.89% | Lsb Industries |
| EBITDA Margin (TTM) | 8.59% | N/A | N/A |
| Return on Equity | -6.51% | -115.46% | Lsb Industries |
| Return on Assets (TTM) | -0.26% | -26.14% | Lsb Industries |
| Free Cash Flow (TTM) | $-5.72M | $-28.07M | Lsb Industries |
| 1-Year Return | -10.39% | 356.37% | Asp Isotopes |
| Price-to-Sales Ratio (TTM) | 0.96 | 201.67 | Lsb Industries |
| Enterprise Value | $897.88M | $740.82M | Lsb Industries |
| EV/Revenue Ratio | 1.67 | 168.16 | Lsb Industries |
| Gross Profit Margin (TTM) | 15.32% | 29.67% | Asp Isotopes |
| Revenue per Share (TTM) | $8 | $0 | Lsb Industries |
| Earnings per Share (Diluted) | $-0.46 | $-0.59 | Lsb Industries |
| Beta (Stock Volatility) | 1.28 | 3.39 | Lsb Industries |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Lsb Industries vs Asp Isotopes Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Lsb Industries | -3.24% | -5.17% | -13.00% | 5.45% | -15.47% | -7.01% |
| Asp Isotopes | -3.72% | 4.37% | 31.64% | 60.69% | 47.94% | 88.66% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Lsb Industries | -10.39% | -47.47% | 331.33% | -64.16% | -42.02% | 35.09% |
| Asp Isotopes | 356.37% | 232.50% | 232.50% | 232.50% | 232.50% | 232.50% |
Performance & Financial Health Analysis: Lsb Industries vs Asp Isotopes
| Metric | LXU | ASPI |
|---|---|---|
| Market Information | ||
| Market Cap | $515.06M | $888.46M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 554,098 | 3,789,974 |
| 90 Day Avg. Volume | 447,873 | 4,297,911 |
| Last Close | $7.16 | $9.32 |
| 52 Week Range | $4.88 - $9.68 | $1.95 - $10.82 |
| % from 52W High | -26.03% | -13.86% |
| All-Time High | $37.85 (May 30, 2011) | $10.82 (Jul 25, 2025) |
| % from All-Time High | -81.08% | -13.86% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.08% | 0.31% |
| Quarterly Earnings Growth | -0.69% | 0.31% |
| Financial Health | ||
| Profit Margin (TTM) | -0.06% | 0.39% |
| Operating Margin (TTM) | 0.09% | -7.22% |
| Return on Equity (TTM) | -0.07% | -1.15% |
| Debt to Equity (MRQ) | 98.92 | 84.08 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $6.89 | $0.59 |
| Cash per Share (MRQ) | $1.74 | $0.75 |
| Operating Cash Flow (TTM) | $46.09M | $-16,894,872 |
| Levered Free Cash Flow (TTM) | $-48,557,500 | $-20,013,620 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Lsb Industries vs Asp Isotopes
| Metric | LXU | ASPI |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 210.50 | -15.52 |
| Forward P/E | 12.79 | -64.80 |
| PEG Ratio | 12.79 | -64.80 |
| Price to Sales (TTM) | 0.96 | 201.67 |
| Price to Book (MRQ) | 1.04 | 16.47 |
| Market Capitalization | ||
| Market Capitalization | $515.06M | $888.46M |
| Enterprise Value | $897.88M | $740.82M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.67 | 168.16 |
| Enterprise to EBITDA | 12.07 | -26.48 |
| Risk & Other Metrics | ||
| Beta | 1.28 | 3.39 |
| Book Value per Share (MRQ) | $6.89 | $0.59 |
Financial Statements Comparison: Lsb Industries vs Asp Isotopes
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | LXU | ASPI |
|---|---|---|
| Revenue/Sales | $143.43M | $1.10M |
| Cost of Goods Sold | $129.05M | $774,765 |
| Gross Profit | $14.38M | $326,840 |
| Research & Development | N/A | $1.53M |
| Operating Income (EBIT) | $4.47M | $-7.95M |
| EBITDA | $26.26M | $-8.23M |
| Pre-Tax Income | $-1.92M | $-8.53M |
| Income Tax | $-283,000 | $-70,720 |
| Net Income (Profit) | $-1.64M | $-8.46M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | LXU | ASPI |
|---|---|---|
| Cash & Equivalents | $15.03M | $55.97M |
| Total Current Assets | $299.33M | $59.03M |
| Total Current Liabilities | $119.47M | $8.18M |
| Long-Term Debt | $503.88M | $36.96M |
| Total Shareholders Equity | $490.56M | $45.73M |
| Retained Earnings | $206.02M | $-64.62M |
| Property, Plant & Equipment | $875.51M | $1.02M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | LXU | ASPI |
|---|---|---|
| Operating Cash Flow | $-4.60M | $-7.16M |
| Capital Expenditures | N/A | $-2.36M |
| Free Cash Flow | $-14.03M | $-5.53M |
| Debt Repayment | $-5.60M | $-262,304 |
| Common Stock Repurchase | $0 | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | LXU | ASPI |
|---|---|---|
| Shares Short | 2.12M | 16.34M |
| Short Ratio | 4.37 | 4.67 |
| Short % of Float | 0.04% | 0.24% |
| Average Daily Volume (10 Day) | 554,098 | 3,789,974 |
| Average Daily Volume (90 Day) | 447,873 | 4,297,911 |
| Shares Outstanding | 71.62M | 72.07M |
| Float Shares | 53.38M | 54.53M |
| % Held by Insiders | 0.26% | 0.23% |
| % Held by Institutions | 0.54% | 0.36% |
Dividend Analysis & Yield Comparison: Lsb Industries vs Asp Isotopes
| Metric | LXU | ASPI |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | $0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |